This topic contains a solution. Click here to go to the answer

Author Question: A nurse provides teaching to a patient who has had a hysterectomy and is about to begin hormone ... (Read 13 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
A nurse provides teaching to a patient who has had a hysterectomy and is about to begin hormone therapy to manage menopausal symptoms. Which statement by the patient indicates understanding of the teaching?
 
  a. Because I am not at risk for uterine can-cer, I can take hormones indefinitely.
  b. I can take estrogen to reduce my risk of cardiovascular disease.
  c. I should take the lowest effective dose for the shortest time needed.
  d. I will need a progestin/estrogen combi-nation since I have had a hysterectomy.

Question 2

A patient is being treated for chemotherapy-induced nausea and vomiting (CINV) with ondansetron Zofran and dexamethasone.
 
  The patient reports getting relief during and imme-diately after chemotherapy but has significant nausea and vomiting several days after each che-motherapy treatment. What will the nurse do? a. Contact the provider to discuss increasing the dose of ondansetron.
  b. Suggest giving prolonged doses of dex-amethasone.
  c. Suggest adding aprepitant Emend to the medication regimen.
  d. Tell the patient to ask the provider about changing the ondansetron to aprepitant.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

missalyssa26

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

C
For patients who have undergone hysterectomy, progestin is unnecessary; estrogen-only prepara-tions still carry increased risk of breast cancer and should be taken in the lowest effective dose for the shortest time possible. Even though uterine cancer is no longer a possibility, breast cancer is still a risk. Studies have shown no protection against coronary heart disease but increased risk of stroke and breast cancer with estrogens.

Answer to Question 2

C
The current regimen of choice for patients taking highly emetogenic drugs consists of three agents: aprepitant plus dexamethasone plus a 5-HT3 antagonist, such as ondansetron. Aprepitant has a prolonged duration of action and can prevent delayed CINV as well as acute CINV. In-creasing the dose of ondansetron will not help treat the delayed CINV. Glucocorticoids should be given intermittently and for short periods to avoid side effects. Changing the ondansetron to aprepitant is not recommended.




maychende

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Wow, this really help


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Excellent

 

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

For a complete list of videos, visit our video library